Predicting optimal partners, combinatorial dosing schedules and clinical outcomes of beta-lactams using PKPD and mechanistic in vitro models

Initial project amount was ca. 132500 EUR. There was a cost extension granted of ca. 22500 EUR granted (end project Dec 31, 2020)

Acronym: 
newBLMcombo
Author: 
Ramón García, Santiago
Principal researcher: 
Santiago Ramón García
Managing entity: 
ARAID
Scope: 
Internacional
Entidades participantes: 
Fundación ARAID
GlaxoSmithKline Investigación y Desarrollo, S.L.
Number of researchers: 
2
Start date: 
04/2018
End date: 
12/2020
Entidad financiadora
Financing entity: 
Tres Cantos Open Lab Foundation
Presupuesto
Total budget: 
155.000€